Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Agilent Technologies Inc(A)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for A
11/05/2026: A (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Agilent Technologies is a specialized provider of analytical instruments, software, and services used in life sciences, diagnostics, and chemical testing. The company benefits from a high-margin recurring revenue model driven by its massive installed base of analytical equipment, which fosters customer loyalty. Its primary growth strategy revolves around expanding into high-value niches like cell analysis and personalized medicine. However, Agilent faces risks from cyclical pharmaceutical R&D spending, intense competition from major diversified life science firms, and geopolitical sensitivities. The stock is often considered a strong fit for investors seeking stable growth and consistent dividend income, though investors should monitor lab spending trends and international regulatory environments.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers steady growth linked to R&D spending rather than hyper-growth cycles. |
| Momentum investor | Weak fit | The stock often exhibits lower volatility and does not typically fit high-momentum trading patterns. |
| Value investor | Mixed fit | Valuation is often tied to market premiums for stable life science tool providers. |
| Dividend investor | Strong fit | Agilent provides reliable, growing dividends backed by strong recurring cash flows. |
| Low-risk investor | Strong fit while signal remains positive | The company's business model is resilient with a high percentage of non-discretionary revenue. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can experience sensitivity to broader market sell-offs and sector-specific sentiment shifts. |
| Valuation risk | Medium | As a quality-focused stock, it can trade at premium multiples that require consistent earnings delivery. |
| Competition risk (analytical instruments) | Medium / high | Intense competition from well-capitalized peers can pressure margins and market share. |
| Business quality | Strong | Agilent's strong moat in analytical chemistry and lab services provides business stability. |
| Dividend income | Low / none | Dividend income is stable but generally not the primary driver for total return compared to capital gains. |
| Execution risk | Medium | The company must successfully integrate acquisitions and manage complex global supply chains. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 14.09% | Avg. Invested days 50 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 11/05/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 49.95B USD | Price to earnings Ratio 34.6 | 1Y Target Price 182.05 |
Price to earnings Ratio 34.6 | 1Y Target Price 182.05 | ||
Volume (30-day avg) 2.2M shares | Beta 1.24 | 52 Weeks Range 107.98 - 182.99 | Updated Date 11/04/2026 |
52 Weeks Range 107.98 - 182.99 | Updated Date 11/04/2026 | ||
Dividends yield (FY) 0.58% | Basic EPS (TTM) 5.12 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Life Sciences & Applied Markets | Chromatography and mass spectrometry instruments used in food, environmental, and forensic testing. | This is the core instrument business that brings customers into the Agilent ecosystem. |
| Agilent CrossLab | Maintenance services, software platforms, and consumables. | This provides the 'razor-and-blade' model, ensuring steady, predictable income. |
| Diagnostics & Genomics | Clinical testing, pathology, and genomic research reagents. | This segment offers higher growth potential through personalized medicine applications. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 34.6 | Forward PE 25.97 | Enterprise Value 51.66B | Price to Sales(TTM) 6.78 |
Enterprise Value 51.66B | Price to Sales(TTM) 6.78 | ||
Enterprise Value to Revenue 7.01 | Enterprise Value to EBITDA 25.38 | Shares Outstanding 281.93M | Shares Floating 281.23M |
Shares Outstanding 281.93M | Shares Floating 281.23M | ||
Percent Insiders 0.19 | Percent Institutions 94.9 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.